Search | CATIE - Canada's source for HIV and hepatitis C information

Jump to Navigation Jump to Content

Sort Results

Filter by Specific Population

Filter by Infection

Filter by Resource Category

Research summary (remove)

Search results

Current filters: HIV drugs, Treatment, Research summary

108 search results

1
2
3
4
5

Revisiting TDF + FTC as a potential preventive for COVID-19: From TreatmentUpdate 238
2020, CATIE
Research summary - Webpage
Triple therapy with interferon-beta + Kaletra + ribavirin: From TreatmentUpdate 237
2020, CATIE
Research summary - Webpage
Kaletra—from HIV to SARS to COVID-19: From TreatmentUpdate 237
2020, CATIE
Research summary - Webpage
Kaletra disappointing in people severely ill with COVID-19: 2020, CATIE
Research summary - Webpage
Dolutegravir and TAF or TDF—safety issues and weight gain: From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage
From wasting to obesity—the changing issue of weight in HIV: From TreatmentUpdate 235
2020, CATIE
Research summary - Webpage
Fostemsavir compassionate access program: From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage
Fostemsavir in treatment-experienced people: From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage
The debut of fostemsavir: From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage
Doravirine begins to be listed on formularies: From TreatmentUpdate 234
2019, CATIE
Research summary - Webpage

1
2
3
4
5

Production of this Web site has been made possible through a financial contribution from the Public Health Agency of Canada.

We comply with the HONcode standard for trustworthy health information: verify here.

Please note that some content on this website contains language, information and images related to sexuality and drug use, and may not be intended for people of all ages. CATIE ensures that these resources, developed to help prevent the transmission of HIV, hepatitis C and other infections, are written and reviewed by health experts for content accuracy.